• PDHA1 Succinylation Drives α-Ketoglutarate–Mediated Immune E

  2026-07-20

  This study uncovers how succinylation of PDHA1 at lysine 83 in cholangiocarcinoma reprograms tumor metabolism, leading to α-ketoglutarate accumulation and suppression of macrophage antigen presentation. The findings highlight a metabolic-immune axis that underpins tumor immune evasion and suggest targeting PDHA1 succinylation as a strategy to overcome chemotherapy resistance.

• Self-Assembling Virus-Mimicking Particles for Targeted mRNA

  2026-07-20

  This study introduces a modular, self-assembling enveloped virus-mimicking particle (EVMP) platform that enables efficient, programmable mRNA delivery to extrahepatic organs such as the lungs and spleen. By combining engineered peptides and precise lipid envelope modifications, the work addresses longstanding barriers of tissue targeting, immunogenicity, and scalability in mRNA therapeutics, paving the way for broader clinical applications.

• Hepatic Cellular Uptake of PEGylated Iron Oxide Nanoparticle

  2026-07-19

  This study systematically unravels how the size and PEGylation of iron oxide nanoparticles dictate their interactions with distinct hepatic cell types. The findings revise current understanding of liver nanoparticle clearance, revealing nuanced roles for hepatocytes and stellate cells and providing design guidance for targeted nanomedicine applications.

• Canagliflozin: SGLT2 Inhibitor Workflows for Renal & Diabete

  2026-07-18

  Canagliflozin’s precision as a selective SGLT2 inhibitor enables reproducible modeling of glucose metabolism and mitochondrial function in diabetic and hypertensive kidney research. Discover optimized protocols, troubleshooting strategies, and practical insights from the latest mitochondrial remodeling studies.

• Triacetin: Mechanisms, Benchmarks, and Translational Frontie

  2026-07-17

  Triacetin (glyceryl triacetate) is emerging as a pivotal biochemical reagent for metabolic regulation and oncology research. This article synthesizes the latest mechanistic insights—spanning HDAC-8 inhibition to AMPK activation—with practical protocol guidance, competitive benchmarking, and a forward-looking perspective on translational opportunities. By linking primary findings from recent peer-reviewed studies and showcasing APExBIO’s Triacetin (BA1710), we highlight new standards for reproducibility, safety, and scientific innovation in life sciences.

• DiR (DiIC 18 (7)) Transforms Live Cell Membrane Imaging

  2026-07-17

  DiR (DiIC 18 (7)) stands out for ultra-stable, near-infrared membrane labeling in both live and fixed samples, revolutionizing long-term cell and EV tracking. Its rapid diffusion, low cytotoxicity, and deep-tissue imaging capabilities empower workflows from neuronal tracing to next-generation drug delivery studies.

• Dual-Emissive Ru(II) Probes Enhance Imaging of Amyloid-β Fib

  2026-07-16

  This study introduces tris-heteroleptic ruthenium complexes as ratiometric, dual-emissive probes for Amyloid β-Peptide (1-42) and (1-40) fibril detection. The innovation lies in enabling more reliable, quantitative imaging of amyloid aggregation—critical for Alzheimer's disease research—while addressing key technical limitations of single-emission probes.

• HyperScript RT SuperMix for qPCR: Precision cDNA Synthesis i

  2026-07-16

  HyperScript RT SuperMix for qPCR delivers robust, reproducible cDNA synthesis from challenging RNA templates, streamlining gene expression analysis even with low-concentration or structurally complex samples. Leveraging advanced enzyme engineering, it empowers researchers to decode intricate neurodegenerative mechanisms and optimize data reliability in demanding qRT-PCR applications.

• Multiplexed ACE2 Libraries Reveal SARS-CoV-2 Receptor Shifts

  2026-07-15

  This study introduces a high-throughput assay using multiplexed ACE2 variant libraries to systematically map how SARS-CoV-2 spike protein variants alter receptor usage. The approach clarifies the molecular shifts underlying cross-species transmission risk and provides a template for large-scale host-pathogen compatibility screens.

• HBsAg Hijacks TBK1 to Suppress IFN-I and Trigger Early Autop

  2026-07-15

  This study uncovers how hepatitis B surface antigen (HBsAg) directly manipulates TANK-binding kinase 1 (TBK1), leading to suppressed type I interferon (IFN-I) production and induction of incomplete autophagy. The findings reveal a novel mechanism for HBV immune evasion with implications for antiviral and innate immunity research.

• Capecitabine in Assembloid Models: Next-Gen Tumor-Targeted I

  2026-07-14

  Explore how Capecitabine (N4-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine) is advancing translational cancer research through its unique mechanistic selectivity, especially within sophisticated assembloid models that recapitulate the tumor microenvironment. This article delivers actionable guidance for leveraging Capecitabine’s tumor-targeted activation, apoptosis pathways, and compatibility with patient-derived systems, setting a new benchmark for preclinical oncology workflows.

• Multidimensional Ionizable Lipid Design for Organ-Selective

  2026-07-14

  This study introduces a streamlined, multidimensional strategy for synthesizing diverse ionizable lipids (ILs) via the Ugi four-component reaction, enabling efficient and organ-selective mRNA delivery using lipid nanoparticles. The findings reveal how IL structural modulation can direct tissue targeting and enhance mRNA transfection, laying groundwork for more precise and potent mRNA therapeutics.

• Honokiol Triggers Paraptosis in APL via mTOR and MAPK Pathwa

  2026-07-13

  This study reveals that honokiol induces paraptosis-like, non-apoptotic cell death in acute promyelocytic leukemia (APL) cells through simultaneous activation of mTOR and MAPK signaling pathways. The findings delineate a caspase-independent mechanism for leukemia cell death, offering new perspectives for treating drug-resistant APL.

• Bafilomycin A1: Precision V-ATPase Inhibitor for Lysosomal F

  2026-07-13

  Bafilomycin A1 stands as the gold-standard V-ATPase inhibitor for dissecting intracellular pH regulation and lysosomal dynamics in advanced cell biology assays. This guide unpacks practical protocols, experimental troubleshooting, and actionable insights drawn directly from breakthrough autophagy and immune-evasion research.

• Preserving Native Protein Structure: Strategic Imperatives f

  2026-07-12

  This thought-leadership article explores the mechanistic and strategic advantages of native protein gel electrophoresis for acidic proteins, focusing on the APExBIO Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit (PI ≤ 7.0). Integrating recent findings in precision oncology and platform disease modeling, it provides translational researchers with actionable guidance to accelerate discovery while maintaining protein integrity.

454 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page